Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Assessment of the potential for host-targeted iminosugars UV-4 and UV-5 activity against filovirus infections in vitro and in vivo.
Warfield KL, Warren TK, Qiu X, Wells J, Mire CE, Geisbert JB, Stuthman KS, Garza NL, Van Tongeren SA, Shurtleff AC, Agans KN, Wong G, Callahan MV, Geisbert TW, Klose B, Ramstedt U, Treston AM. Warfield KL, et al. Among authors: shurtleff ac. Antiviral Res. 2017 Feb;138:22-31. doi: 10.1016/j.antiviral.2016.11.019. Epub 2016 Nov 28. Antiviral Res. 2017. PMID: 27908828
Development of a new vaccine for the prevention of Lassa fever.
Geisbert TW, Jones S, Fritz EA, Shurtleff AC, Geisbert JB, Liebscher R, Grolla A, Ströher U, Fernando L, Daddario KM, Guttieri MC, Mothé BR, Larsen T, Hensley LE, Jahrling PB, Feldmann H. Geisbert TW, et al. Among authors: shurtleff ac. PLoS Med. 2005 Jun;2(6):e183. doi: 10.1371/journal.pmed.0020183. Epub 2005 Jun 28. PLoS Med. 2005. PMID: 15971954 Free PMC article.
Identification and characterization of potent small molecule inhibitor of hemorrhagic fever New World arenaviruses.
Bolken TC, Laquerre S, Zhang Y, Bailey TR, Pevear DC, Kickner SS, Sperzel LE, Jones KF, Warren TK, Amanda Lund S, Kirkwood-Watts DL, King DS, Shurtleff AC, Guttieri MC, Deng Y, Bleam M, Hruby DE. Bolken TC, et al. Among authors: shurtleff ac. Antiviral Res. 2006 Feb;69(2):86-97. doi: 10.1016/j.antiviral.2005.10.008. Epub 2005 Nov 28. Antiviral Res. 2006. PMID: 16343651 Free PMC article.
Standardization of the filovirus plaque assay for use in preclinical studies.
Shurtleff AC, Biggins JE, Keeney AE, Zumbrun EE, Bloomfield HA, Kuehne A, Audet JL, Alfson KJ, Griffiths A, Olinger GG, Bavari S; Filovirus Animal Nonclinical Group (FANG) Assay Working Group. Shurtleff AC, et al. Viruses. 2012 Dec 6;4(12):3511-30. doi: 10.3390/v4123511. Viruses. 2012. PMID: 23223188 Free PMC article. Review.
A systematic screen of FDA-approved drugs for inhibitors of biological threat agents.
Madrid PB, Chopra S, Manger ID, Gilfillan L, Keepers TR, Shurtleff AC, Green CE, Iyer LV, Dilks HH, Davey RA, Kolokoltsov AA, Carrion R Jr, Patterson JL, Bavari S, Panchal RG, Warren TK, Wells JB, Moos WH, Burke RL, Tanga MJ. Madrid PB, et al. Among authors: shurtleff ac. PLoS One. 2013;8(4):e60579. doi: 10.1371/journal.pone.0060579. Epub 2013 Apr 5. PLoS One. 2013. PMID: 23577127 Free PMC article.
HSPA5 is an essential host factor for Ebola virus infection.
Reid SP, Shurtleff AC, Costantino JA, Tritsch SR, Retterer C, Spurgers KB, Bavari S. Reid SP, et al. Among authors: shurtleff ac. Antiviral Res. 2014 Sep;109:171-4. doi: 10.1016/j.antiviral.2014.07.004. Epub 2014 Jul 11. Antiviral Res. 2014. PMID: 25017472
32 results